Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services organization (MSO) for retina specialists, from Webster Equity Partners. The…
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, announced today the successful closing of a $78 million Series E funding round, led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new funding…
Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests at the 61st Annual Meeting of the American Society of…
Palleon Pharmaceuticals, a clinical-stage company leading innovation in glyco-immunology for autoimmune diseases and cancer, today announced results from the Phase 1/2 GLIMMER-01 trial of E-602. This first-in-class human sialidase enzyme therapeutic was tested in combination with the PD-1 inhibitor cemiplimab…
Sunshine Health, Florida’s largest managed care organization and a subsidiary of Centene Corporation (NYSE: CNC), has announced the appointment of Charlene Zein as Plan President and Chief Executive Officer, effective November 3, 2024. With nearly 20 years of experience in…
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, has announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. Now available for clinicians to order, the IPS test is a multimodal biomarker designed to serve…
Square Knot Health, a leader in technology-driven kidney transplant care, has achieved outstanding results with its innovative care model designed to help patients navigate the complexities of kidney transplantation. The company’s unique approach streamlines the transplant process, improving access and…
Cofactor Genomics, Inc., a clinical-stage company focused on advancing precision medicine through RNA decoding, has announced the publication of results from its PREDAPT clinical trial (NCT04510129) in head and neck squamous cell carcinoma (HNSCC). The study highlights the clinical validity…
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition is expected to enhance Maravai and its subsidiary, TriLink BioTechnologies,…
GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced today the launch of a secondary underwritten public offering of 13,281,302 shares of its common stock (the “GEHC Shares”). The company is not selling any shares and will not receive any proceeds from…
BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, has announced an exclusive partnership with KRISHGEN BioSystems. KRISHGEN, a prominent provider of life science research tools and services with over two decades of experience…
SBC Medical Group Holdings (California, USA, CEO: Aikawa Yoshiyuki), a provider of management support to medical institutions globally, has entered into a business partnership with MEDIROM Corporation (Headquarters: Minato-ku, Tokyo, CEO: Eguchi Koji). MEDIROM operates over 300 relaxation studios nationwide…